Blog
RSS FeedPosted by Michael Wonder on 20 Dec 2022
Refreshed National Medicines Policy
20 December 2022 - The Australian Government has released an updated and strengthened National Medicines Policy. ...
Posted by Michael Wonder on 19 Dec 2022
New report indicates COVID-19 vaccines saved Australia’s economy
19 December 2022 - Medicines Australia welcomes the latest peer-reviewed research paper indicating the rollout of the COVID-19 vaccinations significantly ...
Posted by Michael Wonder on 18 Dec 2022
EQ-5D-Y-3L value sets, valuation methods and conceptual questions
12 December 2022 - The measurement and valuation of child health-related quality of life is a rapidly evolving field. ...
Posted by Michael Wonder on 16 Dec 2022
Recommendations made by the PBAC – November 2022
16 December 2022 - The outcomes from the November 2022 PBAC meeting are now available. ...
Posted by Michael Wonder on 07 Dec 2022
Updated eligibility for COVID-19 oral treatment
7 December 2022 - COVID-19 treatments can be taken in your own home and can help reduce your symptoms. ...
Posted by Michael Wonder on 06 Dec 2022
Molnupiravir ‘effective Covid-19 anti-viral’: acting CMO Michael Kidd
6 December 2022 - Acting chief medical officer Michael Kidd has contradicted the nation’s top advisers on Covid-19 treatments on ...
Posted by Michael Wonder on 04 Dec 2022
Anti-viral drug should not be first choice in treating COVID-19
3 December 2022 - The most widely prescribed anti-viral drug in Australia, molnupiravir, should no longer be routinely given for ...
Posted by Michael Wonder on 03 Dec 2022
Hopes $55k breast cancer drug Keytruda will get PBS listing
3 December 2022 - Women with triple negative breast cancer have been given new hope that immunotherapy drug Keytruda will ...
Posted by Michael Wonder on 02 Dec 2022
Agenda for the December 2022 PBAC intracycle meeting
2 December 2022 - The agenda for the December 2022 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 30 Nov 2022
Schedule of Pharmaceutical Benefits - 1 December 2022
1 December 2022 - The December 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 29 Nov 2022
External consultation on the draft revised post-market review framework (deadline extension)
29 November 2022 - The Department of Health and Aged Care has received a request to extend the consultation period on ...
Posted by Michael Wonder on 28 Nov 2022
Type 2 diabetes drug shortage: Victoria’s Ozempic, Trulicity supplies limited until March
28 November 2022 - Type 2 diabetes sufferers are spending hours driving around the suburbs begging pharmacists for a drug that’s ...
Posted by Michael Wonder on 27 Nov 2022
Cheaper medicines for high cholesterol and chronic heart failure
28 November 2022 - From 1 December 2022, Australians with high cholesterol, chronic heart failure, and a potentially life-threatening blood cell ...
Posted by Michael Wonder on 27 Nov 2022
Cost of life-saving heart disease drugs slashed, saving patients thousands
27 November 2022 - Life-saving medicines that tackle Australia's biggest killer are about to be added to the Pharmaceutical Benefits ...
Posted by Michael Wonder on 24 Nov 2022
Outcome in relation to discussion of COVID-19 oral treatments – November 2022 PBAC meeting
24 November 2022 - A PBAC outcome in relation to discussion of COVID-19 oral treatments at the November 2022 meeting has ...